Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

[1] Drake CG(2010)Prostate cancer as a model for tumour immunotherapy Nat Rev Immunol 10 580-593

[2] Dudley ME(2002)Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 850-854

[3] Wunderlich JR(2005)Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma Nat Med 11 986-991

[4] Robbins PF(2009)Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial Clin Cancer Res 15 7036-7044

[5] Neelapu SS(2002)Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores Am J Clin Pathol 117 471-477

[6] Kwak LW(1989)A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry Br J Cancer 60 887-892

[7] Kobrin CB(2004)Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines Hematology 9 207-215

[8] Slingluff CL(2005)Functions of granulocyte-macrophage colony-stimulating factor Crit Rev Immunol 25 405-428

[9] Petroni GR(2012)Antigen specific T-cell responses against tumor antigens are controlled by regulatory T cells in patients with prostate cancer J Urol 187 1458-1465

[10] Olson WC(2001)Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer Prostate 47 222-229

[1] Drake CG(2010)Prostate cancer as a model for tumour immunotherapy Nat Rev Immunol 10 580-593

[2] Dudley ME(2002)Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 850-854

[3] Wunderlich JR(2005)Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma Nat Med 11 986-991

[4] Robbins PF(2009)Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial Clin Cancer Res 15 7036-7044

[5] Neelapu SS(2002)Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores Am J Clin Pathol 117 471-477

[6] Kwak LW(1989)A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry Br J Cancer 60 887-892

[7] Kobrin CB(2004)Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines Hematology 9 207-215

[8] Slingluff CL(2005)Functions of granulocyte-macrophage colony-stimulating factor Crit Rev Immunol 25 405-428

[9] Petroni GR(2012)Antigen specific T-cell responses against tumor antigens are controlled by regulatory T cells in patients with prostate cancer J Urol 187 1458-1465

[10] Olson WC(2001)Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer Prostate 47 222-229